Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased inflammatory and reduced regulatory B cell capacity

Medicine & Life Sciences

• Regulatory B-Lymphocytes 100%
• B-Lymphocyte Subsets 83%
• Relapsing-Remitting Multiple Sclerosis 82%
• B-Lymphocytes 51%
• Antibodies 36%
• Multiple Sclerosis 33%
• Glatiramer Acetate 13%
• Cytokines 11%
• Immunomodulation 10%
• Antigen Presentation 10%
• T-Lymphocyte Subsets 10%
• Plasma Cells 9%
• Autoimmunity 9%
• Cell- and Tissue-Based Therapy 8%
• Interleukin-10 8%
• Immunoglobulins 8%
• Autoimmune Diseases 8%
• Interleukin-6 7%
• Memory 6%
• Cell Proliferation 6%
• T-Lymphocytes 5%